Evolent Health, Inc Class A Common Stock (EVH) — Analysis Summary
Evolent Health, Inc Class A Common Stock (EVH) has a market cap of $480.50M with year-over-year revenue growth of -26.6%. Net margin stands at -28.5%. The stock trades at a P/E ratio of -1.0.
Key Takeaways
- Revenue changed -26.6% year-over-year
- Net margin of -28.5%
- P/E ratio of -1.0
Compared to other companies in the SERVICES-MANAGEMENT SERVICES sector, EVH posted revenue growth of -26.6% and trades at a P/E of -1.0.
Evolent Health, Inc Class A Common Stock (EVH)
PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Interest coverage at -6.2x — earnings do not cover interest payments
Operating margin at -20.4% — material operating losses
Net margin at -24.1% — significant losses
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
Sector
SERVICES-MANAGEMENT SERVICES
Employees
4,200
Headquarters
ARLINGTON, VA
Exchange
XNYS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.